Biotech

All Articles

8 months after a $213M fundraise, genetics editor Volume produces cuts

.After rearing $213 million in 2023-- one of the year's largest exclusive biotech shots-- Volume Bio...

BioMarin builds exec team with biotech vets-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of significant leadership hirings, firings and a...

Biopharma Q2 VC hit highest degree since '22, while M&ampA slowed down

.Venture capital backing right into biopharma rose to $9.2 billion all over 215 sell the 2nd fourth ...

Bicara, Zenas look for IPOs to press late-phase resources towards market

.Bicara Therapies as well as Zenas Biopharma have offered clean motivation to the IPO market along w...

Genentech to close cancer cells immunology analysis division

.Genentech is going to shut its own cancer immunology analysis division, and also system mind as wel...

Kezar falls strong tumor yet to verify its well worth in phase 1 test

.Kezar Life Sciences is dropping its own dim phase 1 strong cyst drug as the biotech goes all-in on ...

Acelyrin loses izokibep, dismisses 3rd of personnel

.Despite izokibep maintaining its newfound winning streak in the medical clinic, Acelyrin is no long...

Rivus' period 2 obesity-related heart failure test reaches endpoint

.Rivus Pharmaceuticals has actually plumped up the prospects of its fat-busting, muscle-sparing medi...

Ovid stops preclinical work, IV course after soticlestat fail

.Ovid Rehab already showed last month that it was actually trimming back its own headcount as the co...

Eli Lilly opens $700M nucleic acid R&ampD center in Boston ma Port

.Eli Lilly has actually opened a $700 thousand R&ampD center in the Boston ma Port, increasing its R...